B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Cefozopran

182 PubMed studies analyzed ยท 7 RCTs ยท Evidence Score: 50.8

Research Domains

Cefozopran has been studied across 9 research domains including ๐Ÿซ Respiratory, ๐Ÿ”ฌ Oncology, ๐Ÿ˜ด Sleep, ๐Ÿง  Focus & Attention, ๐Ÿ›ก๏ธ Immunity. The primary research focus is ๐Ÿซ Respiratory with 13% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cefozopran is generated deterministically from 182 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.